Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a study involving the use of Magnetic Resonance Imaging (MRI) contrast agents called
Gadavist. The purpose of this study is to look at the safety (what are the side effects) and
efficacy (how well does it work) of Gadavist when used for taking images of the brain and
spine. The results of the MRI will be compared to the results of images taken without
Gadavist.